论文部分内容阅读
作者统计了1972～1981年10年间治疗的1016例非何杰金氏淋巴瘤,其中淋巴咽环的病例342例,Ⅱ期病例为180例。放射治疗在淋巴咽照射野与全颈部行35～55Gy的照射,有下颈部、腋窝、纵隔淋巴结肿大时,仅用小斗蓬或斗蓬照射野进行了治疗。单纯放疗82例,其他并用化疗,其半数在放疗前合并使用COP2周期以下,其余的并用COP3～4周期或VEMP等3～6个月。观察期间3年6个月至12年6个月。结果表明,全部病例的2年及5年生存率,分别为72％;57％;2年及5年非复发率为57％,50％。从组织型区分,DH的2年及5年生存率为78％,64％,而DPDL分别为56％,31％。2年及5年的不复发率,DH为62％,55％,
The authors counted 1,016 cases of non-Hodgkin’s lymphoma treated during the 10 years from 1972 to 1981, including 342 cases of lymphopharyngeal rings and 180 cases of stage II cases. Radiation therapy was performed on the 35-55 Gy irradiation of the lymphatic pharyngeal irradiation field and the entire neck. When there was swelling of the lower neck, axilla, and mediastinal lymph nodes, the treatment was performed only with a small canopy or cape irradiation field. In 82 cases of radiotherapy alone, and other combined use of chemotherapy, half of the patients had combined COP2 cycles before radiotherapy, and the remaining patients used COP 3 to 4 cycles or VEMP for 3 to 6 months. The observation period was 3 years 6 months to 12 years 6 months. The results showed that the 2-year and 5-year survival rates for all cases were 72% and 57%, respectively; the non-recurrence rates for 2 and 5 years were 57% and 50%. From the organizational type, the 2-year and 5-year survival rates of DH were 78% and 64%, respectively, while DPDL were 56% and 31%, respectively. The non-recurrence rate of 2 years and 5 years, DH is 62%, 55%,